Michelle Staudt to Herpesvirus 8, Human
This is a "connection" page, showing publications Michelle Staudt has written about Herpesvirus 8, Human.
Connection Strength
1.171
-
The Rta/Orf50 transactivator proteins of the gamma-herpesviridae. Curr Top Microbiol Immunol. 2007; 312:71-100.
Score: 0.282
-
Promoter switching allows simultaneous transcription of LANA and K14/vGPCR of Kaposi's sarcoma-associated herpesvirus. Virology. 2006 Jun 20; 350(1):192-205.
Score: 0.268
-
The tumor microenvironment controls primary effusion lymphoma growth in vivo. Cancer Res. 2004 Jul 15; 64(14):4790-9.
Score: 0.238
-
Viral latent proteins as targets for Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) induced lymphoma. Curr Drug Targets Infect Disord. 2003 Jun; 3(2):129-35.
Score: 0.220
-
Distinct p53, p53:LANA, and LANA complexes in Kaposi's Sarcoma--associated Herpesvirus Lymphomas. J Virol. 2010 Apr; 84(8):3898-908.
Score: 0.087
-
Comparison of the Rta/Orf50 transactivator proteins of gamma-2-herpesviruses. J Virol. 2004 May; 78(10):5491-9.
Score: 0.059
-
Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling. Blood. 2007 Mar 01; 109(5):2165-73.
Score: 0.017